21-gene recurrence score and receipt of chemotherapy in patients with breast cancer
Thursday, August 27, 2015 - 21:20
in Health & Medicine
Use of the 21-gene recurrence test score was associated with lower chemotherapy use in high-risk patients and greater use of chemotherapy in low-risk patients compared with not using the test among a large group of Medicare beneficiaries, according to a new article.